Laboratorios Quimica Son's, S.A. de C.V.
🚨 Critical Risk
FEI: 3012825182 • Heroica Puebla De Zaragoza, Puebla • MEXICO
FEI Number
3012825182
Location
Heroica Puebla De Zaragoza, Puebla
Country
MEXICOAddress
Avenida 23 Poniente No. 2302, Col. El Aguila, Puebla, Heroica Puebla De Zaragoza, Puebla, Mexico
Critical Risk
FDA Import Risk Assessment
This firm has an extensive history of FDA import refusals with severe violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 12/12/2025 | 64GCL07ESTRADIOL (ESTROGEN) | Division of Southeast Imports (DSEI) | |
| 6/3/2025 | 62GDE42INDOMETHACIN (ANTI-INFLAMMATORY) | Division of Southeast Imports (DSEI) | |
| 3/4/2025 | 60SBY07PRECIPITATED CALCIUM CARBONATE (ANTACID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2025 | 54AEY02VITAMIN B1 (THIAMINE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2025 | 61HBY11SULFATHIAZOLE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2025 | 60LBF01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/4/2025 | 64LBJ03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/27/2025 | 64LDY03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/27/2025 | 66VDY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/26/2025 | 62GDA42INDOMETHACIN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/4/2024 | 61FDL55CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/29/2024 | 62GDY99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/29/2024 | 62GDY42INDOMETHACIN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/10/2024 | 61LDY06DIPHENADIONE (ANTI-COAGULANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/15/2024 | 61WDJ04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | Division of Southeast Imports (DSEI) | |
| 10/24/2023 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/28/2023 | 64LDJ03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/27/2023 | 64LDY03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/9/2022 | 62GDA42INDOMETHACIN (ANTI-INFLAMMATORY) | Division of Southeast Imports (DSEI) | |
| 10/5/2022 | 62GDA42INDOMETHACIN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/29/2022 | 60LBE01ACETAMINOPHEN (ANALGESIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/29/2022 | 56KCJ99MISCELLANEOUS ANTIBIOTICS, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/27/2022 | 61SCO99ANTI-ECZEMATIC N.E.C. | Division of Southeast Imports (DSEI) | |
| 9/27/2022 | 64LCO37HYDROCORTISONE (GLUCOCORTICOID) | Division of Southeast Imports (DSEI) | |
| 9/27/2022 | 61VAA01SIMETHICONE (ANTI-FLATULENT) | Division of Southeast Imports (DSEI) | |
| 9/26/2022 | 64LDO37HYDROCORTISONE (GLUCOCORTICOID) | Division of Southeast Imports (DSEI) | |
| 9/22/2022 | 54CBK13L-LYSINE (PROTEIN) | Division of Southeast Imports (DSEI) | |
| 9/15/2022 | 60LCJ37NALBUPHINE HCL (ANALGESIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/23/2022 | 62GDE42INDOMETHACIN (ANTI-INFLAMMATORY) | Division of Southeast Imports (DSEI) | |
| 6/13/2022 | 56BCA03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/13/2022 | 64LCA27FLUOCINOLONE ACETONIDE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2022 | 60QCK07LIDOCAINE | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2022 | 64LCO03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/6/2022 | 61HBJ99ANTI-BACTERIAL, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/2/2021 | 62GCY50NAPROXEN SODIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/30/2021 | 64LDY03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/12/2021 | 60QCA56BENZOCAINE (ANESTHETIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/27/2021 | 60QDC40LIDOCAINE HCL (ANESTHETIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/13/2021 | 64LBH03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/16/2021 | 64LBY03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/8/2020 | 62GCA99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/10/2020 | 62GAC99ANTI-INFLAMMATORY N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/26/2019 | 60LCA82PHENAZOPYRIDINE HCL (ANALGESIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/23/2019 | 61FDL55CIPROFLOXACIN HYDROCHLORIDE (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/26/2019 | 56GDJ99ANTIFUNGAL N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/19/2019 | 64LDY37HYDROCORTISONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 5/30/2019 | 61HDL02TICLATONE (ANTI-BACTERIAL) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/29/2019 | 61WDO04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/16/2018 | 62GDH42INDOMETHACIN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/12/2018 | 60TDA14NALOXONE HCL (ANTAGONIST) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/17/2017 | 65PCA03TAMSULOSIN HCL (REGULATOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/25/2017 | 64LDJ03BETAMETHASONE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/18/2017 | 62VCO69ACYCLOVIR; HYDROCORTISONE (ANTI-VIRAL) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/24/2017 | 61HDA99ANTI-BACTERIAL, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/24/2017 | 61HCY99ANTI-BACTERIAL, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 4/5/2017 | 61GCA04NALIDIXIC ACID (ANTI-BACTERIAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/4/2017 | 66VDA99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 12/9/2016 | 56YCK99ANTIBIOTIC N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/26/2016 | 62KCA10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/7/2016 | 62GCY18DICLOFENAC SODIUM (ANTI-INFLAMMATORY) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 8/19/2016 | 61WDO99A-FUNGAL N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 8/17/2016 | 61TDA29SCOPOLAMINE (ANTI-EMETIC/NAUSEANT) | New Orleans District Office (NOL-DO) | |
| 6/30/2016 | 65QDE22METHOCARBAMOL (RELAXANT) | New Orleans District Office (NOL-DO) | |
| 3/17/2016 | 61WCA47KETOCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Florida District Office (FLA-DO) |
| 3/16/2016 | 62GDA42INDOMETHACIN (ANTI-INFLAMMATORY) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 6/29/2012 | 66VCO99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 8/24/2011 | 62GCE42INDOMETHACIN (ANTI-INFLAMMATORY) | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 10/21/2008 | 61WIY04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 5/17/2007 | 56JCE99LINCOMYCIN N.E.C. | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
| 5/17/2007 | 62KCE10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL) | 75UNAPPROVED | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is Laboratorios Quimica Son's, S.A. de C.V.'s FDA import refusal history?
Laboratorios Quimica Son's, S.A. de C.V. (FEI: 3012825182) has 70 FDA import refusal record(s) in our database, spanning from 5/17/2007 to 12/12/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios Quimica Son's, S.A. de C.V.'s FEI number is 3012825182.
What types of violations has Laboratorios Quimica Son's, S.A. de C.V. received?
Laboratorios Quimica Son's, S.A. de C.V. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Laboratorios Quimica Son's, S.A. de C.V. come from?
All FDA import refusal data for Laboratorios Quimica Son's, S.A. de C.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.